214143-79-0 Usage
General Description
Pyrrolo[1,2-a]quinoxalin-4(5H)-one, 1,2,3,3a-tetrahydro-, (3aR)- (9CI) is a chemical compound with a molecular formula of C9H8N2O. It is a heterocyclic compound containing a pyrrolo-quinoxaline ring system and a tetrahydroquinoline core, with a tetrahydrofuran ring fused to the quinoxaline ring. Pyrrolo[1,2-a]quinoxalin-4(5H)-one, 1,2,3,3a-tetrahydro-, (3aR)- (9CI) has potential applications in medicinal chemistry and drug discovery due to its structural features, which may contribute to its biological activity. The (3aR)- stereoisomer of this compound specifically refers to the three-dimensional arrangement of its atoms, indicating the position of the substituents on the tetrahydroquinoline ring. Further research and investigation may uncover the pharmaceutical relevance and potential therapeutic uses of this chemical compound.
Check Digit Verification of cas no
The CAS Registry Mumber 214143-79-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,1,4,1,4 and 3 respectively; the second part has 2 digits, 7 and 9 respectively.
Calculate Digit Verification of CAS Registry Number 214143-79:
(8*2)+(7*1)+(6*4)+(5*1)+(4*4)+(3*3)+(2*7)+(1*9)=100
100 % 10 = 0
So 214143-79-0 is a valid CAS Registry Number.
214143-79-0Relevant articles and documents
Biphenyl derivatives and drug composition
-
, (2008/06/13)
A biphenyl derivative represented by the following general formula (1) and a pharmaceutically acceptable salt thereof: [In the formula (1), A represents a single bond, —CH2—, —CO—, —CS— or —SO2—; B represents a single bond or —CH2—; R1represents a hydrogen atom, —OH, —NR11R12(wherein R11and R12each independently represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms), —OCOCH3, or a halogen atom; R2represents a hydrogen atom or R1and R2form a group ═O together; R3represents a hydrogen atom or an alkyl group having 1 to 4 carbon atoms; provided that in the formula, the absolute configuration of the position a may be either R or S]. The compound of the present invention has considerably high safety and efficacy and is useful as, in particular, a vasopressin receptor antagonist.
